Literature DB >> 3334974

Risk of genitourinary malignancies after cancer of the prostate.

R S Greenberg1, E D Rustin, W S Clark.   

Abstract

The risk of second malignancies was evaluated in all men in metropolitan Atlanta who were initially diagnosed as having prostate cancer between January 1, 1975 and December 31, 1982. The cohort of 3675 men was observed through the end of calendar year 1984, yielding a total of 11,916 man-years of observation. Within this population 220 second cancers were diagnosed at sites other than the prostate as compared with 181.2 cancers expected based upon incidence rates for the local general population. Excesses of second malignancies were found in the urethra, kidney and bladder, as well as for melanoma of the skin. The increased risk of second neoplasms was generally greater in men younger than 70. The associated genitourinary malignancies tended to occur within 3 years of the prostatic cancer. Although increased clinical surveillance of this population could explain some of the observed excess of second cancers, these findings also are consistent with multiple cancers arising from shared etiologic factors.

Entities:  

Mesh:

Year:  1988        PMID: 3334974     DOI: 10.1002/1097-0142(19880115)61:2<396::aid-cncr2820610232>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Indium-111 Capromab Pendetide (ProstaScint(®)) Demonstrates Renal Cell Carcinoma and Aortocaval Nodal Metastases from Prostate Adenocarcinoma.

Authors:  Tanvir Rizvi; Chunli Deng; Patrice K Rehm
Journal:  World J Nucl Med       Date:  2015 Sep-Dec

2.  Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.

Authors:  David S Yee; Shahrokh F Shariat; William T Lowrance; Joseph R Sterbis; Kinjal C Vora; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni; Jaspreet S Sandhu
Journal:  J Urol       Date:  2010-03-17       Impact factor: 7.450

Review 3.  Multiple primary tumours of the urogenital system: our cases and a review of the literature.

Authors:  A S Ozdamar; E Y Gültekin; A Gökalp
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

4.  Multiple (five) synchronous primary malignant neoplasms of dissimilar histogenesis including a malignant fibrous histiocytoma of the bladder.

Authors:  K Weingärtner; M D Melekos; E W Gerharz; U Köhl; K Neumann; H Riedmiller
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

5.  Multiple primary malignant neoplasms in urologic patients.

Authors:  Osman Inci; Esat Kaya; Bulent Alagol; Irfan Huseyin Atakan; Sabahattin Aydin; Hasan Ereselli
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

6.  Lymph node non-Hodgkin's lymphoma incidentally discovered during a nephrectomy for renal cell carcinoma.

Authors:  Sergio Fernandez-Pello; Luis Rodriguez Villamil; Ivan Gonzalez Rodriguez; Victoria Venta; Javier Cuervo; Carmen Luz Menéndez
Journal:  World J Clin Cases       Date:  2013-06-16       Impact factor: 1.337

Review 7.  Second primary cancers after radiation for prostate cancer: a review of data from planning studies.

Authors:  Louise Murray; Ann Henry; Peter Hoskin; Frank-Andre Siebert; Jack Venselaar
Journal:  Radiat Oncol       Date:  2013-07-08       Impact factor: 3.481

8.  Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.

Authors:  Jae Young Joung; Jiwon Lim; Chang-Mo Oh; Kyu-Won Jung; Hyunsoon Cho; Sung Han Kim; Ho Kyung Seo; Weon Seo Park; Jinsoo Chung; Kang Hyun Lee; Young-Joo Won
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.